Rezultati iskanja Romejko-Jarosinska, J

1.	Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial Pettengell, R; Uddin, R; Boumendil, A ... Bone marrow transplantation (Basingstoke), 06/2021, Letnik: 56, Številka: 6 Journal Article Recenzirano We report the 12-year follow-up of the prospective randomized EBMT LYM1 trial to determine whether the benefit of brief duration rituximab maintenance (RM) on progression-free survival (PFS) in ...	Celotno besedilo Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
2.	Effect of episil (R) oral liquid on oral mucositis severity and duration in HSCT patients Legert, K. G.; Svanberg, Anncarin; Zuckerman, T. ... BONE MARROW TRANSPLANTATION, 2016, Letnik: 51 Journal Article, Conference Proceeding Recenzirano	Celotno besedilo Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
3.	OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION Romejko‐Jarosinska, J.; Paszkiewicz‐Kozik, E.; Popławska, L. ... Hematological oncology, June 2019, 2019-06-00, 20190601, Letnik: 37, Številka: S2 Journal Article Recenzirano	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
4.	AUTOLOGOUS STEM CELL TRANSPLANT WITH HIGH DOSE MELPHALAN PREPARATIVE REGIMEN IS SAFE AND EFFECTIVE FOR ELDERLY MULTIPLE MYELOMA PATIENTS IN THE ERA OF TRIPLE INDUCTION THERAPY Czyz, A.; Romejko‐Jarosinska, J.; Szeremet, A. ... Hematological oncology, June 2019, 2019-06-00, 20190601, Letnik: 37, Številka: S2 Journal Article Recenzirano	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
5.	PRIMARY BREAST DIFFUSE LARGE B‐CELL LYMPHOMA. CLINICAL FEATURES AND OUTCOME IN 55 PATIENTS. POLISH LYMPHOMA RESEARCH GROUP STUDY Romejko‐Jarosinska, J.; Paszkiewicz‐Kozik, E.; Sokołowska‐Drozd, J. ... Hematological oncology, June 2019, 2019-06-00, 20190601, Letnik: 37, Številka: S2 Journal Article Recenzirano	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
6.	R‐CHOP is not effective regimen in CD5(+)DLBCL diagnosed by flow‐cytometry/immunohistochemistry, karyotype and BCL2/BCL6 status and expression Rymkiewicz, G.; Romejko‐Jarosinska, J.; Paszkiewicz‐Kozik, E. ... Hematological oncology, June 2017, 20170601, Letnik: 35, Številka: S2 Journal Article Recenzirano Odprti dostop	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK PDF
7.	DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL Pettengell, R.; Uddin, R.; Boumendil, A. ... Hematological oncology, June 2017, 2017-06-00, 20170601, Letnik: 35, Številka: S2 Journal Article Recenzirano Odprti dostop	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK PDF
8.	R‐ DAEPOCH as a first line treatment for high grade B cell lymphoma and diffuse large B cell lymphoma with unfavorable features Romejko‐Jarosinska, J.; Rymkiewicz, G.; Paszkiewicz‐Kozik, E. ... Hematological oncology, June 2017, 2017-06-00, 20170601, Letnik: 35, Številka: S2 Journal Article Recenzirano Odprti dostop	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK PDF
9.	CHARACTERISTICS AND TREATMENT OUTCOMES OF AGGRESSIVE HIGH GRADE B CELL LYMPHOMA WITH MYC AND BCL 6 REARRANGEMENTS Jarosinska, J. Romejko; Rymkiewicz, G.; Grygalewicz, B. ... Hematological oncology, 06/2023, Letnik: 41, Številka: S2 Journal Article Recenzirano	Celotno besedilo Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
10.	Outcome of primary gastrointestinal compared to nodal diffuse large B cell lymphoma in a series of consecutive patients treated at a single institution Romejko-Jarosinska, J.; Osowiecki, M.; Paszkiewicz-Kozik, E. ... Annals of oncology, 10/2016, Letnik: 27 Journal Article Recenzirano Odprti dostop	Celotno besedilo Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP PDF

1.

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial
Pettengell, R; Uddin, R; Boumendil, A ... Bone marrow transplantation (Basingstoke), 06/2021, Letnik: 56, Številka: 6
Journal Article

Recenzirano

We report the 12-year follow-up of the prospective randomized EBMT LYM1 trial to determine whether the benefit of brief duration rituximab maintenance (RM) on progression-free survival (PFS) in ...

Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

2.

Effect of episil (R) oral liquid on oral mucositis severity and duration in HSCT patients
Legert, K. G.; Svanberg, Anncarin; Zuckerman, T. ... BONE MARROW TRANSPLANTATION, 2016, Letnik: 51
Journal Article, Conference Proceeding

Recenzirano

Celotno besedilo

Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

3.

OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION
Romejko‐Jarosinska, J.; Paszkiewicz‐Kozik, E.; Popławska, L. ... Hematological oncology, June 2019, 2019-06-00, 20190601, Letnik: 37, Številka: S2
Journal Article

Recenzirano